接受齐多夫定治疗的艾滋病患者的血清胸苷激酶 - Suppr | 超能文献

Serum thymidine kinase in AIDS patients treated with zidovudine.

作者信息

Pedersen C, Ingeberg S

出版信息

Lancet. 1987 Aug 22;2(8556):460. doi: 10.1016/s0140-6736(87)91002-6.

DOI:10.1016/s0140-6736(87)91002-6

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Serum thymidine kinase in AIDS patients treated with zidovudine.接受齐多夫定治疗的艾滋病患者的血清胸苷激酶

Lancet. 1987 Aug 22;2(8556):460. doi: 10.1016/s0140-6736(87)91002-6.

2

Serum thymidine kinase--a marker of bone marrow toxicity during treatment with zidovudine.血清胸苷激酶——齐多夫定治疗期间骨髓毒性的标志物。

AIDS. 1989 Nov;3(11):743-6. doi: 10.1097/00002030-198911000-00009.

3

Wernicke's encephalopathy in AIDS patient treated with zidovudine.

Lancet. 1987 Apr 18;1(8538):919-20. doi: 10.1016/s0140-6736(87)92892-3.

4

Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC.

N Engl J Med. 1988 Mar 17;318(11):708. doi: 10.1056/nejm198803173181113.

5

The blood transfusion service and zidovudine treatment for AIDS.艾滋病的输血服务与齐多夫定治疗

Br Med J (Clin Res Ed). 1987 Dec 5;295(6611):1486. doi: 10.1136/bmj.295.6611.1486-a.

6

[AIDS and antiretroviral agents: specificity of azidothymidine].[艾滋病与抗逆转录病毒药物：叠氮胸苷的特异性]

Srp Arh Celok Lek. 1987 Nov;115(11):1099-109.

7

AIDS commentary. Azidothymidine.艾滋病评论。叠氮胸苷。

J Infect Dis. 1988 Mar;157(3):427-31. doi: 10.1093/infdis/157.3.427.

8

Update on AZT for AIDS.

Med Lett Drugs Ther. 1987 Dec 18;29(755):113-4.

9

Zidovudine (AZT).

Lancet. 1987 Apr 25;1(8539):957-8.

10

Increased frequency of haemarthroses in haemophilic patient treated with zidovudine.接受齐多夫定治疗的血友病患者关节积血频率增加。

Lancet. 1988 Jun 25;1(8600):1454-5. doi: 10.1016/s0140-6736(88)92259-3.

引用本文的文献

1

Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications.胸苷激酶：一种对非霍奇金淋巴瘤具有预后价值且具有广泛潜在临床应用的肿瘤标志物。

Ann Hematol. 1992 Jul;65(1):1-5. doi: 10.1007/BF01715117.

2

Serum thymidine kinase, a possible marker for monitoring the effect of bone marrow transplant treatment in early recovery phase.血清胸苷激酶，一种在骨髓移植治疗早期恢复阶段用于监测治疗效果的潜在标志物。

Ann Nucl Med. 1992 May;6(2):79-82. doi: 10.1007/BF03164646.